Skip to main content
Clinical Trials/NCT02820207
NCT02820207CompletedNot Applicable

Vascular Surgery Department of Beijing Tsinghua Chang Gung Hospital

Beijing Tsinghua Chang Gung Hospital1 site in 1 country50 target enrollmentStarted: January 13, 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
50
Locations
1
Primary Endpoint
the incidence of ischemia shock

Study Overview

Brief Summary

OBJECTIVE/BACKGROUND: Intraplaque neovascularization is one of the most important risk factors for unstable carotid plaque. This study was designed to evaluate whether carotid intraplaque neovascularization (IPN) can be accurately assessed by contrast enhanced ultrasound (CEUS).

METHODS: Preoperative CEUS analysis of 50 carotid artery stenosis patients would be compared to histopathology performed on their plaques excised by carotid endarterectomy (CEA) with CD34 and MMP9 staining.

Detailed Description

  1. To enroll 50 cases of patients suffering from carotid artery stenosis continuously, the investigators perform contrast enhanced ultrasound on patients for identifying the vulnerable plagues and taking high resolution MR inspection to analysis those plagues at the same time.
  2. All patients undergo carotid endarterectomy. The vulnerable ingredients of carotid plaques such as intraplaque neovascularization and bleeding are identified by pathological examination and immunohistochemical staining.
  3. To evaluate the accuracy of CEUS for identifying carotid vulnerable plague compared with high resolution MR.
  4. The investigators divide patients into the stable group and the vulnerable group based on the results of CEUS inspection. To analysis the incidence of postoperative complications such as stroke and mortality within 30 days and to compare the differences between the two groups.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
50 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • The patients with ischemic symptom whose carotid stenosis were more than 50%
  • The patients without ischemic symptom whose carotid stenosis were more than 70%

Exclusion Criteria

  • Confirmed with severe intracranial vascular lesions
  • Suffering from the large area cerebral infarction or critical stroke sequela
  • Restenosis after CEA or CAS
  • Suffering from severe coronary heart disease, respiratory failure,the hypertension difficult to controled
  • Patients with malignant tumor or expected life < 2 years

Outcomes

Primary Outcomes

the incidence of ischemia shock

Time Frame: within 30 days after operations

The incidence of ischemic stroke was defined as the number of cases of postoperative cerebral infarction divided by the total number of cases

Secondary Outcomes

  • the incidence of restenosis(6 months after operations)
  • the incidence of all-cause mortality(within 30 days after operations)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Keqiang Zhao

Attending Doctor

Beijing Tsinghua Chang Gung Hospital

Study Sites (1)

Loading locations...

Similar Trials